A pilot study to identify perceived barrier and motivating factors of primary veterinarians in the USA for specialty referral and management of atopic dermatitis with allergen‐specific immunotherapy

2020 ◽  
Vol 31 (5) ◽  
pp. 371
Author(s):  
Sarah Flanagan ◽  
Anthea Schick ◽  
Thomas P. Lewis
Keyword(s):  
Atopic Dermatitis ◽  
Pilot Study ◽  
Specific Immunotherapy ◽  
Motivating Factors ◽  
Allergen Specific Immunotherapy ◽  
The Usa

Rush allergen specific immunotherapy protocol in feline atopic dermatitis: a pilot study of four cats

2005 ◽  
Vol 16 (5) ◽  
pp. 324-329 ◽  
Author(s):  
ANN M. TRIMMER ◽  
CRAIG E. GRIFFIN ◽  
MONA J. BOORD ◽  
WAYNE S. ROSENKRANTZ
Keyword(s):  
Atopic Dermatitis ◽  
Pilot Study ◽  
Specific Immunotherapy ◽  
Allergen Specific Immunotherapy

scholarly journals Allergen-Specific Immunotherapy with Monomeric Allergoid in a Mouse Model of Atopic Dermatitis

PLoS ONE ◽  
2015 ◽  
Vol 10 (8) ◽  
pp. e0135070 ◽  
Author(s):  
Nadezda Shershakova ◽  
Elena Bashkatova ◽  
Alexander Babakhin ◽  
Sergey Andreev ◽  
Alexandra Nikonova ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Mouse Model ◽  
Specific Immunotherapy ◽  
Allergen Specific Immunotherapy

Allergen-specific immunotherapy induces regulatory T cells in an atopic dermatitis mouse model

Allergy ◽  
2018 ◽  
Vol 73 (9) ◽  
pp. 1801-1811 ◽  
Author(s):  
J. U. Shin ◽  
S. H. Kim ◽  
J. Y. Noh ◽  
J. H. Kim ◽  
H. R. Kim ◽  
...  
Keyword(s):  
T Cells ◽  
Atopic Dermatitis ◽  
Regulatory T Cells ◽  
Mouse Model ◽  
Specific Immunotherapy ◽  
Allergen Specific Immunotherapy

Supplementary therapy in canine atopic dermatitis

2019 ◽  
Vol 24 (8) ◽  
pp. 400-407
Author(s):  
Sue Paterson
Keyword(s):  
Fatty Acids ◽  
Atopic Dermatitis ◽  
Specific Immunotherapy ◽  
Essential Fatty Acids ◽  
Topical Therapy ◽  
Allergen Specific Immunotherapy ◽  
Canine Atopic Dermatitis ◽  
Adequate Control ◽  
Inflammatory Drugs ◽  
Anti Inflammatory

Therapy for canine atopic dermatitis can be described as foundation or supplementary. Foundation therapy, which refers to allergen-specific immunotherapy, ciclosporin, glucocorticoids, lokivetmab and oclacitinib, is needed in all but the mildest of cases of canine atopic dermatitis. Supplementary therapies include drugs such as antihistamines, essential fatty acids, topical therapy and other systemic anti-inflammatory drugs. While it is uncommon for any of these supplementary drugs to provide adequate control of many cases of canine atopic dermatitis, they can reduce the frequency of relapse and reduce the amount of foundation therapy that is required when used in combination with them.

Allergen-specific immunotherapy induces Th1 shift in dogs with atopic dermatitis

2004 ◽  
Vol 102 (1-2) ◽  
pp. 19-31 ◽  
Author(s):  
Masayuki Shida ◽  
Michiyo Kadoya ◽  
Seong-Jun Park ◽  
Koji Nishifuji ◽  
Yasuyuki Momoi ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Specific Immunotherapy ◽  
Allergen Specific Immunotherapy
Sign in / Sign up

Export Citation Format

Share Document